Efficacy of 150kHz tumor treating fields (TTFields) and cisplatin or pemetrexed for the treatment of mesothelioma cells in vitro von Weinberg, U., Munster, M., Gotlib, K., Schneiderman, R.S., Porat, Y., Voloshin Sela, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E., Kinzel, A., Palti, Y.

Volltext

Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models von Weinberg, U., Kaynan, N., Voloshin Sela, T., Davidi, S., Porat, Y., Shteingauz, A., Munster, M., Schneiderman, R.S., Tempel Brami, C., Zeevi, E., Gotlib, K., Cahal, S., Giladi, M., Kirson, E., Kinzel, A., Palti, Y.

Volltext

Milnor invariants and twisted Whitney towers von Conant, J., Schneiderman, R., Teichner, P.

Volltext

Depth-dependent compressive properties of normal aged human femoral head articular cartilage: relationship to fixed charge density von Chen, S.S., Falcovitz, Y.H., Schneiderman, R., Maroudas, A., Sah, R.L.

Volltext

Incubator weaning in preterm infants and associated practice variation von Schneiderman, R, Kirkby, S, Turenne, W, Greenspan, J

Volltext

Alternating Electric Fields (TTFields) Inhibit Repair of DNA Damage Induced by Ionizing Radiation and Sensitize Glioma and Non-Small Cell Lung Cancer Cells to Radiation von Zielinska-Chomej, K, Giladi, M, Tichon, A, Tu, J, Schneiderman, R, Viktorsson, K, Kirson, E, Palti, Y, Lewensohn, R

Volltext

Aggrecan Turnover in Human Articular Cartilage: Use of Aspartic Acid Racemization as a Marker of Molecular Age von Maroudas, A., Bayliss, M.T., Uchitel-Kaushansky, N., Schneiderman, R., Gilav, E.

Volltext

Disruption of cancer cell replication by alternating electric fields von KIRSON, Eilon D, GURVICH, Zoya, SCHNEIDERMAN, Rosa, DEKEL, Erez, ITZHAKI, Aviran, WASSERMAN, Yoram, SCHATZBERGER, Rachel, PALTI, Yoram

Volltext

P-121 Effects of tumor treating fields (TTFields) on gastric cancer cells and their potential concomitant application with FOLFOX von Flint-Brodsly, N., Zeevi, E., Dor-On, E., Schneiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., León, J., Haber, A., Giladi, M., Weinberg, U., Palti, Y.

Volltext

Simple whitney towers, half-gropes and the arf invariant of a knot von SCHNEIDERMAN, R. O. B

Volltext

P-184 Underlining mechanism for the efficacy of tumor treating fields (TTFields) concomitant with sorafenib for treatment of hepatocellular carcinoma von Davidi, S., Jacobovitch, S., Shteingauz, A., Tempel-Brami, C., Munster, M., Zeevi, E., Dor-On, E., Schneiderman, R., Voloshin, T., Haber, A., Giladi, M.

Volltext

P-255 Effects of tumor treating fields (150 kHz) in combination with FOLFOX on gastric cancer cells in vitro von Zeevi, E., Gotlib, K., Schneiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Giladi, M., Weinberg, U., Palti, Y.

Volltext

P-261 Safety and effectiveness of tumor treating fields combined with sorafenib in preclinical models of hepatocellular carcinoma von Davidi, S., Tempel-Brami, C., Munster, M., Gotlib, K., Zeevi, E., Schneiderman, R., Voloshin, T., Giladi, M., Weinberg, U., Palti, Y.

Volltext

P04.17 Cancer cell lines response to tumor treating fields: results of a meta-analysis von Lavy Shahaf, G, Giladi, M, Schneiderman, R, Kinzel, A, Weinberg, U, Kirson, E, Palti, Y

Volltext

P25.09 Effectiveness of Tumor Treating Fields plus Cisplatin/Pemetrexed Combination in Mesothelioma, in Vitro and in Vivo von Mumblat, H., Martinez, A., Munster, M., Dor-On, E., Schneiderman, R., Porat, Y., Voloshin, T., Davidi, S., Blatt, R., Shteingauz, A., Tempel-Brami, C., Zeevi, E., Lajterer, C., Shmueli, Y., Danilov, S., Haber, A., Giladi, M., Weinberg, U., Palti, Y.

Volltext

P1.06-17 Tumor Treating Fields (150 kHz) Combined with Cisplatin or Pemetrexed Inhibits Mesothelioma Cells in Vitro and in Vivo von Munster, M., Gotlib, K., Schneiderman, R., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

EP1.06-07 In Vivo Studies of Tumor Treating Fields to Upper Torso in Combination with Chemotherapy Show No Additional Toxicities von Giladi, M., Davidi, S., Munster, M., Schneiderman, R., Kaynan, N., Voloshin, T., Porat, Y., Cahal, S., Kirson, E., Weinberg, U., Palti, Y.

Volltext

P04.16 Tumor treating fields affect invasion properties and cell morphology of various cancer cells von Schneiderman, R, Giladi, M, Zeevi, E, Shteingauz, A, Voloshin, T, Porat, Y, Munster, M, Kirson, E, Palti, Y

Volltext

P04.55 Efficacy of Tumor Treating Fields (TTFields) and aurora B kinase inhibitor von Krex, D, Bartmann, P, Temme, A, Schneiderman, R, Voloshin, T, Giladi, M, Kinzel, A, Kirson, E, Weinberg, U, Palti, Y

Volltext

P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling von Porat, Y, Shteingauz, A, Voloshin, T, Schneiderman, R, Giladi, M, Kirson, E, Weinberg, U, Kinzel, A, Palti, Y

Volltext